Literature DB >> 8200026

Opiate and opioid use in patients with refractory headache.

D K Ziegler1.   

Abstract

Opiate and opioid analgesics are commonly used for pain in general and presumably for headache. Codeine, oxycodone and propoxyphene, among the most commonly prescribed, do carry some risk of abuse, and their efficacy in headache patients has not been well studied. In many patients with other kinds of pain, however, both of neoplastic and non-neoplastic origin, chronic opiate use has been demonstrated to be of benefit without adverse side effects. The type of headache patient with intractable pain who needs frequent opiate analgesic and who does not develop addiction or drug abuse is an important subject for research.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200026     DOI: 10.1046/j.1468-2982.1994.1401005.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  6 in total

Review 1.  Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans.

Authors:  Z Katsarava; H C Diener; V Limmroth
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  [Gordian knot: medication overuse headache].

Authors:  Z Katsarava; G Fritsche
Journal:  Schmerz       Date:  2004-10       Impact factor: 1.107

3.  The diagnosis and treatment of chronic migraine: the case for daily scheduled opioid treatment in chronic headache.

Authors:  Iraj Derakhshan
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

Review 4.  Opioid analgesics: comparative features and prescribing guidelines.

Authors:  N I Cherny
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

Review 5.  Analgesic/abortive overuse and misuse in chronic daily headache.

Authors:  H C Diener; Z Katasarva
Journal:  Curr Pain Headache Rep       Date:  2001-12

6.  Pain and psychiatry: a critical analysis and pharmacological review.

Authors:  Donatella Marazziti; Francesco Mungai; Laura Vivarelli; Silvio Presta; Bernardo Dell'Osso
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.